Voya Investment Management LLC Cuts Stock Holdings in DaVita Inc. $DVA

Voya Investment Management LLC lessened its stake in shares of DaVita Inc. (NYSE:DVA) by 63.0% in the third quarter, HoldingsChannel.com reports. The institutional investor owned 8,699 shares of the company’s stock after selling 14,794 shares during the quarter. Voya Investment Management LLC’s holdings in DaVita were worth $1,156,000 as of its most recent filing with the SEC.

A number of other institutional investors and hedge funds have also recently modified their holdings of DVA. Hantz Financial Services Inc. grew its position in shares of DaVita by 48.1% during the 2nd quarter. Hantz Financial Services Inc. now owns 231 shares of the company’s stock valued at $33,000 after purchasing an additional 75 shares in the last quarter. MAI Capital Management boosted its position in DaVita by 23.4% during the second quarter. MAI Capital Management now owns 438 shares of the company’s stock valued at $62,000 after buying an additional 83 shares during the period. NewEdge Advisors LLC raised its holdings in shares of DaVita by 20.8% during the first quarter. NewEdge Advisors LLC now owns 511 shares of the company’s stock valued at $78,000 after acquiring an additional 88 shares in the last quarter. Teacher Retirement System of Texas raised its stake in DaVita by 1.4% in the second quarter. Teacher Retirement System of Texas now owns 6,696 shares of the company’s stock worth $954,000 after buying an additional 94 shares in the last quarter. Finally, Commonwealth of Pennsylvania Public School Empls Retrmt SYS boosted its position in shares of DaVita by 1.2% during the second quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 10,184 shares of the company’s stock valued at $1,451,000 after purchasing an additional 122 shares in the last quarter. 90.12% of the stock is owned by institutional investors.

DaVita Price Performance

Shares of NYSE DVA opened at $113.84 on Wednesday. DaVita Inc. has a 1-year low of $112.54 and a 1-year high of $179.60. The company has a market cap of $8.04 billion, a price-to-earnings ratio of 11.72, a price-to-earnings-growth ratio of 0.86 and a beta of 0.99. The stock’s 50-day moving average is $119.74 and its two-hundred day moving average is $130.27.

DaVita (NYSE:DVA) last posted its quarterly earnings data on Wednesday, October 29th. The company reported $2.51 earnings per share for the quarter, missing analysts’ consensus estimates of $3.17 by ($0.66). DaVita had a negative return on equity of 13,370.89% and a net margin of 5.80%.The company had revenue of $3.42 billion for the quarter, compared to analyst estimates of $3.43 billion. During the same period in the previous year, the business posted $2.59 earnings per share. The firm’s revenue was up 4.8% compared to the same quarter last year. DaVita has set its FY 2025 guidance at 10.350-11.150 EPS. Equities research analysts anticipate that DaVita Inc. will post 10.76 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

DVA has been the subject of several analyst reports. Cowen reissued a “hold” rating on shares of DaVita in a research report on Monday, November 3rd. Zacks Research raised DaVita from a “strong sell” rating to a “hold” rating in a research note on Friday, November 28th. Truist Financial set a $140.00 price objective on DaVita in a report on Tuesday, October 14th. TD Cowen dropped their price target on shares of DaVita from $154.00 to $133.00 and set a “hold” rating for the company in a research note on Monday, November 3rd. Finally, Wall Street Zen downgraded shares of DaVita from a “buy” rating to a “hold” rating in a research note on Saturday, October 11th. One equities research analyst has rated the stock with a Buy rating, six have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus target price of $148.00.

About DaVita

DaVita Inc (NYSE: DVA) is a leading provider of kidney care services, specializing in the management and operation of outpatient dialysis centers for patients with chronic kidney failure and end-stage renal disease. Headquartered in Denver, Colorado, the company offers a comprehensive suite of treatment modalities, including in-center hemodialysis, peritoneal dialysis, and home dialysis therapies. In addition to its core dialysis services, DaVita provides patient education, nutritional counseling, vascular access management and related laboratory services to support kidney health and overall patient well-being.

Since its formation in the mid-1990s through a clinical management services spin-off, DaVita has expanded both organically and through strategic partnerships and acquisitions.